On September 29, 2021, sponsored by Anhui Society of Traditional Chinese Medicine, co-organized by the First Affiliated Hospital of Anhui University of Chinese Medicine, Hema Center of Aalto University, Finland, organized by the Rheumatology Professional Committee of Anhui Society of Traditional Chinese Medicine, Institute of Rheumatology of Anhui Academy of Chinese Medicine, and the Studio of Liu Jian, Famous Doctor of Jianghuai and Provincial Famous Doctor of Traditional Chinese Medicine, "China-Finland Rheumatological disease Medical high-tech online Forum" was held in the hospital. This activity was held in a combination of online and offline. Professor Liu Jian, Vice President of the hospital and director of Institute of Rheumatology, Professor Wang Peng, Dean of Graduate School of Anhui University of Chinese Medicine, Professor Huang Chuanbing, Vice President of the hospital, Professor Wu Hong, School of Pharmacy of Anhui University of Chinese Medicine, More than 30 persons in charge of the hospital's scientific research department, data center, rheumatology and immunology department and doctoral and postgraduate students attended the offline meeting; ProfessorPaul Lillrank, ProfessorMiika Linna, Associate ProfessorPaulus Torkki, Postdoctoral ResearcherAn Chen, Project Manager HenniTenhunen participated online via the live streaming platform. The Chinese side was presided over by Vice President Huang Chuanbing. At the meeting, Liu Jian gave a keynote report on "Building Evidence chain of Xin 'an Jianpi Tongbi Prescription to improve the experience of rheumatic patients". Dr. Sun Yue, Dr. Huang Dan and doctoral students Wen Jianting, Sun Yanqiu and Fang Yanyan from the Department of Rheumatology and Immunology of the hospital, and master students Wang Xin and Wang Jie respectively reported the research results in evidence chain.Professor Paul Lillrank did a presentation on Personalized care with Mass-production Efficiency. Chinese and foreign experts at the meeting had extensive communication and exchanges on topics such as the measurement of rheumatoid and immune disease patients' feelings, in-depth mining of medical big data, construction of virtual medical care management system, academic and technical exchanges, joint training of talents, and reached some consensus.
